IPSNEWS
RAUpdate: Creation of the CENAFyT and its impact on the health sector.
On March 9, 2026, COFEPRIS officially announced the creation of the National Center for Pharmacovigilance and Technovigilance (CENAFYT). This body emerges not as an isolated entity, but as the strategic evolution of the former National Pharmacovigilance Center (CNFV), following the legal modifications made to the General Health Law at the beginning of 2026.
Frequent errors when applying for a Sanitary Import Permit before COFEPRIS through VUCEM
This article explains the most common mistakes when applying for a Sanitary Import Permit before Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and how to prevent them. It is aimed at importers of regulated products and seeks to help them avoid warnings, rejections, and delays in their procedures.
COFEPRIS Electronic Notification: Digitalization and deadline optimization
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has formalized the use of email as an official channel for notification and requirements. This mechanism aims to streamline response times, reduce backlogs, and provide legal certainty to regulated entities by allowing digital tracking of administrative procedures.
Víctor Hugo Borja: Management, challenges, and future
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has entered a new stage under the leadership of Dr. Víctor Hugo Borja Aburto, who took office on January 1, 2026. His administration is part of the consolidation of the universal health system and the execution of the industrial policy established in the Plan México.
COFEPRIS 2025: Regulatory advances and international alignment
By the close of 2025, the Federal Commission for Protection against Sanitary Risks (COFEPRIS), has consolidated a transformation focused on agility, transparency, and international recognition.